Category
6 articles
Most generics sold in the US are made overseas, and most people have no idea how that supply chain actually works — or that they can look it up themselves. Here's an honest look at foreign manufacturing, FDA oversight, and how to think about the savings-versus-safety question without the panic.
Most people know about GoodRx. Far fewer know how to combine it with manufacturer rebates, pharmacy loyalty programs, and insurance timing tricks to pay absolutely nothing for chronic medications. We talked to real patients who cracked the code — and mapped out exactly how they did it.
Insurance companies and pharmacy benefit managers profit every time you pick up a 30-day refill instead of a 90-day supply. The math on what you're losing is genuinely alarming — and getting what you're owed requires knowing exactly how to push back.
The price on your prescription receipt has almost nothing to do with what the drug actually costs to make. A tangled web of backroom deals between pharmacy benefit managers, insurers, and retail chains determines what you pay — and sometimes, ditching your insurance card is the smartest financial move you can make.
A lot of patients feel weird bringing up medication costs with their doctor — like they're admitting something embarrassing. But asking about generics isn't a sign of financial desperation. It's just smart healthcare, and your doctor probably won't push back the way you think.
Two people, same prescription, same diagnosis — one pays $40, the other pays $400. This isn't a glitch in the system. It's the system. We dig into the regional pricing gaps, insurance games, and brand-name markup strategies that keep millions of Americans overpaying for medication they desperately need.